3 Top Healthcare Stocks to Buy in October

Group 1 - Healthcare stocks have underperformed the broader market over the past year due to political tensions and policy uncertainty [1] - Despite short-term challenges, healthcare remains a vital sector with continuous demand for care and innovation, presenting long-term investment opportunities [2] - The weight loss drug market is projected to grow from $15 billion in 2024 to $150 billion by 2035, indicating significant potential for companies like Novo Nordisk [6] Group 2 - Novo Nordisk has seen a 50% decline in shares over the past year, primarily due to competition from compounding pharmacies [4] - The company is preparing to launch an oral version of Wegovy, which could help regain market share [5] - Novo Nordisk is currently trading at a P/E ratio of 16, reflecting market pessimism despite its growth potential [6] Group 3 - Danaher operates in the healthcare tools sector, providing products that assist in drug discovery and development [7] - The company is known for its acquisition strategy, currently owning over 15 businesses across various healthcare-related fields [7]